Manuel A Friese Selected Research

Manuel A Friese Research Topics

Disease

26	Multiple Sclerosis 03/2024 - 08/2005
16	Inflammation (Inflammations) 11/2023 - 12/2007
7	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 11/2023 - 01/2008
7	Autoimmune Diseases (Autoimmune Disease) 12/2021 - 12/2006
6	Glioma (Gliomas) 11/2021 - 12/2003
5	Neoplasms (Cancer) 01/2021 - 12/2003
4	Autoimmune Diseases of the Nervous System 11/2021 - 07/2013
3	Alzheimer Disease (Alzheimer's Disease) 04/2024 - 01/2020
3	Disease Progression 03/2024 - 01/2021
3	COVID-19 01/2023 - 01/2021
3	Demyelinating Diseases (Demyelinating Disease) 01/2023 - 02/2011
3	Encephalitis (Encephalitis, Rasmussen) 11/2021 - 06/2010
3	Infections 11/2021 - 10/2018
3	AIDS-Related Complex (ARC) 01/2021 - 09/2016
3	Ischemic Stroke 11/2014 - 11/2012
3	Stroke (Strokes) 11/2014 - 11/2012
2	Thrombosis (Thrombus) 05/2024 - 01/2021
2	Cognitive Dysfunction 12/2023 - 01/2023
2	Sarcoidosis (Schaumann Disease) 02/2022 - 01/2021
2	Neuroinflammatory Diseases 01/2022 - 01/2019
2	Parkinson Disease (Parkinson's Disease) 01/2020 - 01/2018
2	Neuromyelitis Optica (Devic's Disease) 01/2019 - 03/2017
2	Glioblastoma (Glioblastoma Multiforme) 06/2005 - 12/2003
1	Histiocytosis 05/2024
1	Macular Edema 05/2024
1	Amyloid Plaque 04/2024
1	Hematologic Neoplasms (Hematological Malignancy) 03/2024
1	Dementia (Dementias) 01/2024
1	Memory Disorders (Memory Loss) 11/2023
1	Amyloidosis 11/2023
1	Gliosis 11/2023
1	Cerebral Malaria 11/2023
1	Leukoencephalopathies 01/2023
1	Nervous System Diseases (Neurological Disorders) 10/2022
1	Necrosis 02/2022
1	Aspiration Pneumonia 02/2022
1	Neurosarcoidosis 02/2022
1	Progressive Multifocal Leukoencephalopathy 02/2022
1	Central Nervous System Diseases (CNS Diseases) 01/2022
1	Central Nervous System Infections (Central Nervous System Infection) 11/2021
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2021
1	Experimental Melanoma 01/2021

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 01/2022 - 12/2003
6	AntibodiesIBA 11/2021 - 06/2010
5	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2018 - 12/2006
4	Interleukin-17 (Interleukin 17)IBA 01/2018 - 01/2008
3	CytokinesIBA 04/2024 - 01/2016
3	Amyloid (Amyloid Fibrils)IBA 04/2024 - 01/2023
3	Biomarkers (Surrogate Marker)IBA 11/2023 - 01/2018
3	Messenger RNA (mRNA)IBA 11/2023 - 06/2005
3	Peptides (Polypeptides)IBA 01/2023 - 03/2009
3	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 11/2021 - 07/2013
3	Glutamic Acid (Glutamate)FDA Link 01/2021 - 12/2014
3	AntigensIBA 01/2021 - 03/2013
3	Neuroprotective AgentsIBA 11/2016 - 12/2007
3	CationsIBA 11/2014 - 02/2011
3	micaIBA 09/2006 - 12/2003
2	Alemtuzumab (Campath)FDA Link 12/2023 - 01/2021
2	Adenosine Triphosphate (ATP)IBA 01/2023 - 01/2022
2	VaccinesIBA 01/2021 - 08/2014
2	NAADP (nicotinic acid adenine dinucleotide phosphate)IBA 01/2020 - 11/2014
2	Immunoglobulin G (IgG)IBA 01/2020 - 07/2013
2	Transcription Factors (Transcription Factor)IBA 01/2019 - 01/2016
2	SodiumIBA 11/2016 - 02/2011
2	AutoantigensIBA 12/2014 - 03/2013
2	Ion Channels (Ion Channel)IBA 12/2014 - 04/2014
2	N-Methylaspartate (NMDA)IBA 07/2013 - 06/2010
2	HLA-A*02:01 antigenIBA 06/2012 - 11/2008
2	HLA-A Antigens (HLA-A)IBA 05/2011 - 11/2008
2	Transforming Growth Factor beta (TGF-beta)IBA 09/2006 - 10/2004
2	LigandsIBA 09/2006 - 12/2003
2	Small Interfering RNA (siRNA)IBA 06/2005 - 10/2004
1	cobimetinibIBA 05/2024
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2024
1	Chimeric Antigen ReceptorsIBA 03/2024
1	MicroRNAs (MicroRNA)IBA 11/2023
1	PotassiumIBA 01/2023
1	RNA (Ribonucleic Acid)IBA 01/2023
1	Retinaldehyde (Retinal)IBA 01/2023
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 01/2023
1	nitarsoneIBA 01/2023
1	Infliximab (Remicade)FDA Link 02/2022
1	Adenosine A1 ReceptorIBA 01/2022
1	InterferonsIBA 01/2022
1	Adenosine (Adenocard)FDA LinkGeneric 01/2022
1	Glyburide (Glibenclamide)FDA LinkGeneric 01/2022
1	Histone MethyltransferasesIBA 01/2022
1	Leucine (L-Leucine)FDA Link 11/2021
1	Membrane Proteins (Integral Membrane Proteins)IBA 11/2021
1	metabotropic glutamate receptor 8IBA 01/2021
1	Rituximab (Mabthera)FDA Link 01/2021
1	Monoclonal AntibodiesIBA 01/2021
1	Fibrinolysin FDA Link 01/2021

Therapy/Procedure

9	Therapeutics 03/2024 - 12/2003
3	Immunotherapy 11/2021 - 12/2003
2	Immunomodulation 03/2024 - 03/2013
2	Hematopoietic Stem Cell Transplantation 12/2023 - 01/2021
1	Stem Cell Transplantation 01/2023
1	Drug Prescriptions 10/2022
1	Aftercare (After-Treatment) 02/2022